The concept of membrane fluidity usually refers to a high molecular mobility inside the lipid bilayer which enables lateral diffusion of embedded proteins. Fluids have the ability to flow under an applied shear stress whereas solids resist shear deformations. Biological membranes require both properties for their function: high lateral fluidity and structural rigidity. Consequently, an adequate account must include, in addition to viscosity, the possibility for a nonzero shear modulus. This knowledge is still lacking as measurements of membrane shear properties have remained incomplete so far. In the present contribution we report a surface shear rheology study of different lipid monolayers that model distinct biologically relevant situations. The results evidence a large variety of mechanical behavior under lateral shear flow.
We report an experimental study on the mechanical and permeability properties of giant polymersomes made of diblock (PBD-PEO) and triblock (PEO-PPO-PEO) copolymers. These polymer amphiphiles bear the architecture and macromolecular dimensions adequate for assembling stable flat bilayers with a different hydrophobicity. In the highly hydrophobic case (PBD-PEO) an extremely compact membrane is formed, resulting in rigid polymersomes which represent a permeability barrier against solute transport across. In the case of water soluble PEO-PPO-PEO triblock copolymers, the bilayer structure is less stable in favour of the micellar state; therefore giant vesicles can be solely formed at large PPO contents. These cases (PluronicsÒ L121 and its mixtures with P85 and P105) are characterised by a much lower chain entangling than highly hydrophobic membranes, their polymersomes being softer than those based on PBD-PEO. Pluronic-based polymersomes are also found to be highly permeable to hydrophilic solutes, even remaining undamaged in the case of an extreme osmotic shock. This high permeability together with their high flexibility endows Pluronics polymersomes smart core/shell properties ideal to catch large biomolecules inside and able to resist under osmotic and mechanical stresses.
In this study, the center-of-mass diffusion and shape fluctuations of large unilamellar 1-palmitoyl-2-oleyl-sn-glycero-phosphatidylcholine vesicles prepared by extrusion are studied by means of neutron spin echo in combination with dynamic light scattering. The intermediate scattering functions were measured for several different values of the momentum transfer, q, and for different cholesterol contents in the membrane. The combined analysis of neutron spin echo and dynamic light scattering data allows calculation of the bending elastic constant, kappa, of the vesicle bilayer. A stiffening effect monitored as an increase of kappa with increasing cholesterol molar ratio is demonstrated by these measurements.
The transbilayer diffusion of unlabeled ceramides with different acyl chains (C 6 -Cer, C 10 -Cer, and C 16 -Cer) was investigated in giant unilamellar vesicles (GUVs) and in human erythrocytes. Incorporation of a very small percentage of ceramides (ϳ0.1% of total lipids) to the external leaflet of egg phosphatidylcholine GUVs suffices to trigger a shape change from prolate to pear shape vesicle. By observing the reversibility of this shape change the transmembrane diffusion of lipids was inferred. We found a half-time for unlabeled ceramide flip-flop below 1 min at 37°C. The rapid diffusion of ceramides in a phosphatidylcholine bilayer was confirmed by flip-flop experiments with a spin-labeled ceramide analogue incorporated into large unilamellar vesicles. Shape change experiments were also carried out with human erythrocytes to determine the trans-membrane diffusion of unlabeled ceramides into a biological membrane. Addition of exogenous ceramides to the external leaflet of human erythrocytes did not trigger echinocyte formation immediately as one would anticipate from an asymmetrical accumulation of new amphiphiles in the outer leaflet but only after ϳ15 min of incubation at 20°C in the presence of an excess of ceramide. We interpret these data as being indicative of a rapid ceramide equilibration between both erythrocyte leaflets as indicated also by electron spin resonance spectroscopy with a spin-labeled ceramide. The late appearance of echinocytes could reveal a progressive trapping of a fraction of the ceramide molecules in the outer erythrocytes leaflet. Thus, we cannot exclude the trapping of ceramides into plasma membrane domains.Ceramide is the backbone and an intermediate molecule in the metabolism of sphingolipids. It is a minor lipid component of the plasma membrane of eukaryotic cells and can be generated in vivo by the degradation of sphingomyelin or of gangliosides. Free ceramide was shown to play a role as second messenger for many cellular functions. Its potent biological activity has been extensively reviewed (1, 2). Because enzymes involved in ceramide generation and metabolism are localized in different subcellular compartments, a challenging question remains unanswered: how do such water-insoluble molecules overcome the successive solubility barriers found during traffic between the membranes of different organelles? In addition, the transmembrane orientation of ceramides must be controlled at each step. Ceramide is synthesized on the cytosolic surface of the endoplasmic reticulum and is converted to galactosylceramide in the luminal leaflet of the endoplasmic reticulum. It is not known if this reorientation within the membrane takes place spontaneously or is catalyzed by a protein. The Golgi system also requires regulated ceramide distribution between leaflets as synthesis of glucosylceramide occurs on the cytosolic side and sphingomyelin (SM) 1 on luminal side (3). The transverse diffusion of several sphingolipid derivatives has been measured with spin-labeled and fluorescent analogues ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.